Spots Global Cancer Trial Database for randomized
Every month we try and update this database with for randomized cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC) | NCT00313781 | Prostatic Neopl... | CP-751,871 docetaxel prednisone docetaxel prednisone | 18 Years - | Pfizer | |
| Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC) | NCT01135056 | Hepatocellular ... | SIR-Spheres Sorafenib tosyl... | 18 Years - | Singapore General Hospital | |
| SPCG17: Prostate Cancer Active Surveillance Trigger Trial | NCT02914873 | Prostate Cancer | Active surveill... | - | Uppsala University | |
| Addition of Vandetanib to Standard Therapy Pegliposomal Doxorubicin (PLD) | NCT00862836 | Ovarian Cancer | Vandetanib | 18 Years - | Sanofi | |
| STRIDE - STimulating Immune Response In aDvanced brEast Cancer | NCT00925548 | Breast Cancer | Tecemotide (L-B... Placebo of tece... cyclophosphamid... sodium chloride... | 18 Years - | EMD Serono | |
| Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) | NCT01362140 | MDS | Darbepoetin alf... Placebo | 18 Years - | Amgen | |
| Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer | NCT00215644 | Esophageal Canc... Gastric Cancer | Matuzumab Epirubicin Cisplatin Capecitabine | 18 Years - | Merck KGaA, Darmstadt, Germany | |
| Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial | NCT04534075 | Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Gynecologic Can... | Capsules contai... | 18 Years - 80 Years | Sahlgrenska University Hospital, Sweden | |
| Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases | NCT01508000 | Colorectal Canc... Liver Metastase... KRAS Wild Type ... | FOLFOX6 Bevacizumab Panitumumab Surgery | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Vestibular Schwannoma - Radiosurgery or Expectation: V-REX. | NCT02249572 | Vestibular Schw... | gamma knife rad... | 18 Years - 70 Years | Haukeland University Hospital | |
| Group Versus Individual Acupuncture for Cancer Pain | NCT03641222 | Cancer Pain | Acupuncture | 18 Years - | University of Calgary | |
| Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC | NCT05548504 | Non-small Cell ... Radiotherapy Si... Frailty | Photon Proton | 18 Years - | Odense University Hospital | |
| Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) | NCT01479283 | Infection Bone Neoplasms | 24-Hour Prophyl... 5-Days Prophyla... | 12 Years - | McMaster University | |
| Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma | NCT00132301 | Prostate Cancer | Docetaxel Prednisone | - | VA Office of Research and Development | |
| Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer "DELTA STUDY" | NCT00201890 | Breast Cancer Lymphedema | Lymphatic Massa... | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs) | NCT00857662 | Brain Arteriove... | Onyx TRUFILL | - | Medtronic Neurovascular Clinical Affairs | |
| Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer | NCT01516996 | Oropharyngeal C... Hypopharyngeal ... | docetaxel and c... IMRT Nimotuzumab | 18 Years - 70 Years | The Second People's Hospital of Sichuan | |
| Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma | NCT02863055 | Malignant Pleur... | Nintedanib Placebo | 18 Years - 90 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma | NCT04220749 | Head and Neck C... Oropharyngeal S... | Radiation Trans-Oral Surg... | 18 Years - | Lawson Health Research Institute | |
| A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | NCT01560104 | Non-Small -Cell... | Veliparib Carboplatin paclitaxel placebo | 18 Years - 99 Years | AbbVie | |
| Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) | NCT01147939 | Acute Myeloid L... | Elacytarabine Investigator's ... | 18 Years - | Clavis Pharma | |
| A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients | NCT03013504 | HER2 Positive B... | HD201 Herceptin Docetaxel Epirubicin Cyclophosphamid... | 18 Years - | Prestige Biopharma Limited | |
| Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure | NCT04410042 | Cancer of the B... Limb Salvage | Tranexamic Acid 0.9% sodium chl... | - 24 Years | St. Jude Children's Research Hospital | |
| A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer | NCT02151084 | Biliary Tract C... Gallbladder Car... | Selumetinib Cisplatin Gemcitabine | 18 Years - | University Health Network, Toronto | |
| Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma | NCT04220749 | Head and Neck C... Oropharyngeal S... | Radiation Trans-Oral Surg... | 18 Years - | Lawson Health Research Institute | |
| Home Jejunostomy Feeding Following Esophagectomy/Gastrectomy | NCT01870817 | Esophageal Neop... | Home jejunostom... | 18 Years - | University Hospitals, Leicester | |
| Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal Cancer | NCT00950820 | Colorectal Neop... | Oxaliplatin, Ca... Oxaliplatin, Ca... | 18 Years - | AIO-Studien-gGmbH | |
| A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC | NCT00369070 | Advanced Non-sq... | Bevacizumab AMG 706 Paclitaxel Carboplatin | 18 Years - | Amgen | |
| KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC | NCT04265534 | Non-Small Cell ... Non-squamous No... Non-Squamous No... KEAP1 Gene Muta... NRF2 Gene Mutat... NFE2L2 Gene Mut... | Telaglenastat Carboplatin Che... Pemetrexed Chem... Pembrolizumab I... Placebo Folic acid 400 ... Vitamin B12 100... Dexamethasone 4... | 18 Years - | Calithera Biosciences, Inc | |
| Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) | NCT01147939 | Acute Myeloid L... | Elacytarabine Investigator's ... | 18 Years - | Clavis Pharma | |
| Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy | NCT04090736 | Leukemia, Myelo... | Pevonedistat Azacitidine | 18 Years - | PETHEMA Foundation | |
| Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer | NCT01516996 | Oropharyngeal C... Hypopharyngeal ... | docetaxel and c... IMRT Nimotuzumab | 18 Years - 70 Years | The Second People's Hospital of Sichuan | |
| Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma | NCT00132301 | Prostate Cancer | Docetaxel Prednisone | - | VA Office of Research and Development | |
| Postoperative Bleeding Prevention in Massive Bone Tumour Resection | NCT02153593 | Blood Loss Bone Tumour | Tranexamic Acid Fibrin glue Electrocauteriz... | 18 Years - | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | |
| Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis | NCT00190385 | Compensated Cir... | Ultrasonographi... | 30 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
| A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | NCT01560104 | Non-Small -Cell... | Veliparib Carboplatin paclitaxel placebo | 18 Years - 99 Years | AbbVie | |
| Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA) | NCT04943627 | Advanced Cancer Metastatic Cerv... | Balstilimab (BA... Topotecan Vinorelbine Gemcitabine Irinotecan Pemetrexed | 18 Years - | Agenus Inc. | |
| Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) | NCT01362140 | MDS | Darbepoetin alf... Placebo | 18 Years - | Amgen | |
| Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs) | NCT00857662 | Brain Arteriove... | Onyx TRUFILL | - | Medtronic Neurovascular Clinical Affairs | |
| Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial | NCT04534075 | Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Gynecologic Can... | Capsules contai... | 18 Years - 80 Years | Sahlgrenska University Hospital, Sweden | |
| Single Versus Conventional Laparoscopy for Benign Adnexal Disease | NCT01288599 | Ovarian Cyst | Laparoscopic su... | 18 Years - | Sorlandet Hospital HF | |
| A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer | NCT03745222 | Carcinoma, Non-... | Tislelizumab Concurrent chem... Placebo | 18 Years - | Celgene | |
| Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy | NCT04295447 | Prostatic Neopl... | Standard of car... Apalutamide 60M... | 18 Years - | Universität Münster | |
| Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML) | NCT01736683 | Anemia Myelodysplastic... Chronic Myelomo... Low to Intermed... Myelodysplastic... Chronic Myelomo... | Sotatercept | 18 Years - | Merck Sharp & Dohme LLC | |
| CO2 Laser and Open Surgery for T1N0 Glottic SCC With Anterior Commissure Involved | NCT02303457 | Squamous Cell C... | CO2 Laser surge... Open Surgery | 20 Years - 70 Years | Sun Yat-sen University | |
| A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer | NCT03745222 | Carcinoma, Non-... | Tislelizumab Concurrent chem... Placebo | 18 Years - | Celgene | |
| Group Versus Individual Acupuncture for Cancer Pain | NCT03641222 | Cancer Pain | Acupuncture | 18 Years - | University of Calgary | |
| Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer. | NCT02470065 | Non Small Cell ... | Afatinib Immediate surge... | 18 Years - 90 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients | NCT00168181 | Cancer Head and Neck C... | Submandibular g... Salagen | 18 Years - | AHS Cancer Control Alberta | |
| Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC | NCT05548504 | Non-small Cell ... Radiotherapy Si... Frailty | Photon Proton | 18 Years - | Odense University Hospital | |
| Effects of Steroid Tapering on Functional Capacity and Neurocognition | NCT01169415 | Glioblastoma Mu... | Dexamethasone a... Dexamethasone | 18 Years - 70 Years | Duke University | |
| Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2 | NCT04229979 | Acute Myeloid L... | Galinpepimut-S Azacitidine Venetoclax Decitabine Cytarabine Observation GM-CSF Montanide | 18 Years - | Sellas Life Sciences Group | |
| Group Versus Individual Acupuncture for Cancer Pain | NCT03641222 | Cancer Pain | Acupuncture | 18 Years - | University of Calgary | |
| KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC | NCT04265534 | Non-Small Cell ... Non-squamous No... Non-Squamous No... KEAP1 Gene Muta... NRF2 Gene Mutat... NFE2L2 Gene Mut... | Telaglenastat Carboplatin Che... Pemetrexed Chem... Pembrolizumab I... Placebo Folic acid 400 ... Vitamin B12 100... Dexamethasone 4... | 18 Years - | Calithera Biosciences, Inc | |
| Postoperative Bleeding Prevention in Massive Bone Tumour Resection | NCT02153593 | Blood Loss Bone Tumour | Tranexamic Acid Fibrin glue Electrocauteriz... | 18 Years - | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | |
| Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain | NCT02471339 | Neurofibromatos... Plexiform Neuro... | Acceptance and ... | 16 Years - 59 Years | National Institutes of Health Clinical Center (CC) | |
| A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | NCT01560104 | Non-Small -Cell... | Veliparib Carboplatin paclitaxel placebo | 18 Years - 99 Years | AbbVie | |
| The Efficacy Of Mapping For Cognitive Prostate Biopsy | NCT05902637 | Prostate Cancer Prostate Adenoc... Prostatic Neopl... Prostate Diseas... Prostate Cancer... | Performing cogn... Performing cogn... | 40 Years - 90 Years | Marmara University | |
| Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors | NCT02283489 | Head and Neck N... | recombinant hum... Cisplatin injec... Paclitaxel inje... | 18 Years - 70 Years | Chengdu Shi Endor Biological Engineering Technology Co., Ltd | |
| Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer "DELTA STUDY" | NCT00201890 | Breast Cancer Lymphedema | Lymphatic Massa... | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme | NCT01464177 | Recurrent Gliob... | Stereotactic hy... Stereotactic hy... | 18 Years - | University of Sao Paulo | |
| Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC | NCT05548504 | Non-small Cell ... Radiotherapy Si... Frailty | Photon Proton | 18 Years - | Odense University Hospital | |
| Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) | NCT01147939 | Acute Myeloid L... | Elacytarabine Investigator's ... | 18 Years - | Clavis Pharma | |
| 5% KOH Solution vs. Placebo and Diclofenac Gel for the Treatment of Actinic Keratosis | NCT04552327 | Actinic Keratos... | Solcera Placebo Solaraze | 18 Years - | Infectopharm Arzneimittel GmbH | |
| Yiqi Wenjing Prescriptions Preventive Efficacy of Oxaliplatin-induced Peripheral Neuropathy Clinical Trial | NCT04690283 | Chemotherapy-in... Colorectal Canc... | Mimetic granule... Huangqi-Guizhi-... Danggui-Sini gr... | 18 Years - | Nanjing NingQi Medicine Science and Technology Co., Ltd. | |
| Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy | NCT04090736 | Leukemia, Myelo... | Pevonedistat Azacitidine | 18 Years - | PETHEMA Foundation | |
| Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma | NCT02942264 | Brain Tumor Astrocytoma Astroglioma Glioblastoma Gliosarcoma | Zotiraciclib (T... Temozolomide (T... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | NCT01560104 | Non-Small -Cell... | Veliparib Carboplatin paclitaxel placebo | 18 Years - 99 Years | AbbVie | |
| Hydralazine Valproate for Cervical Cancer | NCT00532818 | Metastatic Cerv... | Hydralazine and... Placebo | 18 Years - | National Institute of Cancerología | |
| Sequencing Abiraterone and Enzalutamide in mCRPC | NCT02125357 | Metastatic Cast... | Abiraterone ace... Enzalutamide | 18 Years - | British Columbia Cancer Agency | |
| Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance | NCT00367861 | Sarcoma Gastro-intestin... | interruption of... | 18 Years - | Centre Leon Berard | |
| Distal Pancreatectomy, Minimally Invasive or Open, for Malignancy (DIPLOMA) | NCT04483726 | Pancreatic Duct... | minimally invas... open distal pan... | 18 Years - | University Hospital, Montpellier | |
| Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M... | NCT01118091 | Skin Cancer Melanoma Metastatic Mela... | Aldesleukin CD8 enriched Yo... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors | NCT02283489 | Head and Neck N... | recombinant hum... Cisplatin injec... Paclitaxel inje... | 18 Years - 70 Years | Chengdu Shi Endor Biological Engineering Technology Co., Ltd | |
| Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy | NCT03474094 | Sarcoma,Soft Ti... | Pre-operative r... 2 cycles of ate... Pre-operative r... | 18 Years - | Centre Leon Berard | |
| Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis | NCT01363557 | EGFR-mutated Lu... Brain Metastasi... | whole brain rad... Gefitinib (IRES... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients | NCT00168181 | Cancer Head and Neck C... | Submandibular g... Salagen | 18 Years - | AHS Cancer Control Alberta | |
| Palliation Dysphagia Cancer Oesophagus Stent+Brachytherapy Versus Brachytherapy Only | NCT00653107 | Esophageal Neop... | Stent insertion Brachytherapy Brachytherapy | 18 Years - | Oslo University Hospital | |
| Organoid-based Functional Precision Therapy for Advanced Breast Cancer | NCT06102824 | HER2-negative B... Advanced Breast... | Organoid-guided... Taxane Capecitabine Gemcitabine Vinorelbine Eribulin Anthracycline Carboplatin Utidelone Trastuzumab der... Sacituzumab gov... | 18 Years - 80 Years | Guangdong Provincial People's Hospital | |
| Stress Management in Breast Cancer Patients | NCT01555645 | Breast Cancer Stress | Stress manageme... | 18 Years - | Uppsala University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
